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metabolically stable, in the pH-neutralized gelatin gel, for prolonged periods of time at 20 o C.
Comparisons with glycolysis at 37 o C
The relationship between the glycolytic rate at 20 o C in gels, and what it is known to be at 37 o C in free suspensions was of interest in case gelatin altered RBC metabolism in some unexpected way. The metabolic rate in melted gelatin at 37 o C was the same as in free solution, provided care was taken to adjust the pH of the medium; but might there be an effect in the gel at 20 o C? This can be explored as follows.
Hexokinase is the main flux-controlling enzyme in human RBC glycolysis (32).
Beutler (48) tabulates the relative rates of 28 RBC enzymes at 25 o C versus 37 o C and hexokinase is stated to be 0.477 ± 0.022. Our experiments were conducted at 20 o C, so assuming a linear dependence of rate over this small temperature range gives the ratio (17/12)  0.477 = 0.337. In other words, the rate of the hexokinase reaction, and hence glycolysis, should be 1/0.337 = 2.97 times faster at 37 o C. The rate at 37 o C was predicted to be 0.67  2.97 = 1.99 mmol [L RBC] -1 h -1 , and 3.65 mmol [L RBC] -1 h -1 for the compressed cells, and 2.38 mmol [L RBC] -1 h -1 for the second relaxed stage, respectively. Therefore, the rate enhancement, consequent upon compression from the relaxed state, was 1.8-fold and the unperturbed rate was consistent with RBCs at 37 o C (32).
fig. S1. Control time course for the experiment in Fig. 1 . The graph shows [3-13 C]L-lactate production from 9.95 mM [1, [6] [7] [8] [9] [10] [11] [12] [13] C]D-glucose by RBCs in gelatin gel, in the presence of 10.0 mM extracellular Ca 2+ , in the relaxed state only, at 20˚C. NMR acquisition parameters were the same as for 
Cs + efflux from RBCs in gels
We explored the possibility of obtaining 133 Cs NMR spectra from RBCs set in gelatin gel. Because the protein concentration outside the cells (gelatin 350 g L -1 ; see Material and Methods) was comparable to that inside, it was not immediately obvious that the two resonances would be resolved. However, as seen in the lower inset of Fig.   3 , the two resonances were well resolved, being separated by   1 ppm.
In gels, it was experimentally more convenient to record 133 Cs + efflux from RBCs, which had been preloaded with 133 Cs + , rather than recording influx. High concentrations of 133 Cs + outside the cells gave a large septet when the gel was stretched or compressed, thus obscuring the smaller emerging intracellular resonance.
This introduced complexity into quantifying the flux; however, this was achievable with lower concentrations, as is described in Materials and Methods. Results from the Cs + -transport experiment that was the counterpart of Fig. 2 are given in Fig. 3 .
At the beginning and the end of the second, compression stage, of the experiment there was a jump in the intensity of the extracellular resonance. This was concluded to be the artefactual loss of 133 Cs + signal as a result of the line broadening brought about by compressing the gelatin; and it was not a consequence of transient-induced changes in the permeability of Piezo1. Specifically, separate experiments in which the sample was melted after compression, before the 133 Cs + spectrum was recorded, showed that there had not been a burst of transport activity in the short time before the next stage of compression or relaxation. Fig. 2 , relaxing the compressed sample led to a return of the reaction rate to a value, which was similar to the previous one in the relaxed stage. The 133 Cs + efflux rate in the third stage of the experiment was 0.80 ± 0.07 mol (L RBC) -1 min -1 ; this lower value is consistent with the system being almost at equilibrium after 6-10 h.
As in
A notable observation, apart from the obvious acceleration of 133 Cs + efflux when the RBCs were compressed, was its reversibility; namely the enhanced transmembrane transport could be 'switched on and off' simply by changing the state of RBC distortion. This reversibility of the phenomenon is a highly significant indicator that such events are possible in vivo.
Complementary 133 Cs + efflux experiment
As a counterpart of the experiment in Fig. 3, fig. S2 shows the results of a Cs + efflux experiment in which the RBCs were first compressed, then relaxed, and then compressed again.
The NMR spectra were processed as for Fig. 3 . For the compressed-stage spectra, the area of the unresolved septet was estimated using nonlinear least squares regression of a mathematical function, composed of seven mixed Gaussian and Lorentzian expressions for the septet and one for the intracellular singlet, onto the data using the function NonlinearModelFit in Mathematica (49). An example of a representative fit, on the third spectrum in the compression stage of the experiment, is shown in the upper-right inset of Fig. 3 . However, the "jump" artefacts in the previous data were in the reverse direction. This is consistent with artefactual signal loss being due to the broadness of the 133 Cs + septet.
The fluxes estimated by regression of lines onto the data in each of the three stages were comparable to those in Fig. 3 . The initial rate was 19.1 ± 1.7 mol (L RBC) -1 min -1 , which was higher than for the second stage of Fig. 3 . This is consistent because in the latter experiment flux had already proceeded for ~5% of the full extent of the reaction.
When the RBCs were relaxed, the efflux slowed down, and on compression it sped up again. As commented in the main text, this reversibility of the "efflux switch" is notable and indicative of the rate-transition not being a result of irreversible damage to membrane structures.
fig. S2. Efflux of Cs + from human RBCs suspended in gelatin gel. Sample was compressed ("70%") (•), relaxed (•), and then compressed ("70%") (•) again, and Cs + efflux was recorded in 12 sequential 133 Cs-NMR spectra in each 2 h stage. Temperature was set to 20 o C. RBCs had been preloaded over 2 d with Cs + in 'Cs-saline' at 21 o C, and then centrifugally washed with 'Na-saline' at 4 o C to remove extracellular Cs + (Materials and Methods). Initial intracellular concentration was 16.5 mmol (L RBC) -1 , calculated as described in Materials and Methods. Data in each stage were fitted with straight lines shown as the solid-line segments. Dotted lines are extrapolations to render changes in slope more obvious. Fitted slopes for the respective stages were (min -1  10 -4 ): 11.6 ± 1.0, 1.5 ± 0.5, and 4.1 ± 0.6. With initial intracellular [Cs + ] = 16.5 mM, the rates correspond to respective effluxes of [mol (L RBC) -1 min -1 ]: 19.1 ± 1.7, 2.5 ± 0.8, and 6.8 ± 1.0 (where ± denotes standard error, and the second-stage rate is significantly different from the first at P < 0.02).
RBC glycolysis in free suspensions -Effect of yoda1
NaCl-saline versus sucrose-saline Table S1 , Rows 1 and 2, and Rows 9 and 10, indicate that yoda1 enhanced the rate of lactate production by a factor of 3.1 and 3.3, respectively, when the RBCs were in an NaCl-saline medium. This efflux rate was more than in the experimental outcome listed at Rows 17 and 18, when the enhancement was 2.3-fold.
However, in a sucrose medium the enhancement was only 1.2-fold. This smaller response was evident in all experiments in which sucrose replaced NaCl as the main osmotic support. It can be explained by fact that yoda1 enhances transmembrane cation exchange via Piezo1. When the extracellular Na + concentration is low in the sucrose medium, the cation leaks into the cells in small amounts so stimulation of Na,K-ATPase does not take place to the same extent as in normal in vivo-like saline media.
Qualitatively, the finding encouraged our use of NaCl-saline medium in all subsequent experiments in which stimulation of glycolysis by yoda1 was to be perturbed by known effectors of Piezo1.
Eosin
Eosin inhibits RBC Ca-ATPase (33), and yet an effect on normal glycolytic flux was only elicited with relatively high concentrations (table S1 Row 4 versus the control in Row 1; and Row 12 versus the control in Row 9). When it was present at 40 µM, it gave no significant enhancement of glycolysis in either the untreated or yoda1-treated RBCs. When present at 120 µM (Rows 12 and 13) it enhanced glycolysis in the non-yoda1-treated RBCs, but brought about no change in rate in the yoda1-treated RBCs.
This suggests an effect that was not dependent on the interaction of yoda1 with Piezo1, but a direct effect on Ca-ATPase as reported previously (33). The stimulation was contrary to expectation because inhibition of Ca-ATPase is supposed to elevate ATP concentration above normal values and hence reduce the glycolytic rate. On the other hand, eosin did not significantly affect the (already major) enhancement of glycolysis brought about by yoda1. Thus, at the concentrations used, eosin-induced activation of glycolysis did not surpass that already achieved with yoda1. We conclude that eosin had an effect on RBC metabolism that was more complex than simply inhibiting Ca-ATPase. This was explored further in relation to direct measurements of 133 Cs + flux (see below).
pCMBS
The mercurial reagent p-chloromercuribenzenesulfonate (pCMBS) reacts with exposed sulfhydryl groups in proteins, including the integral membrane water transport protein aquaporin 1 in human RBCs (34). It enhanced the rate of lactate production in non-yoda1-treated RBCs (table S1 Row 7 compared with Row 1), and diminished the yoda1-enhanced response to around 2/3 this value; viz., 6.4 ± 0.4 versus 9.2 ± 0.2 (Rows 8 and 2, respectively). This suggests that modification of membrane protein(s) increased Ca 2+ leakage into the RBCs that had not been treated with yoda1; and yet the yoda1-induced enhancement was less dramatic in its presence (Table 1 Row 8 compared with control in Row 1). Therefore, we conclude that pCMBS inhibits Piezo1, albeit incompletely under the conditions used. This finding may prove useful in structural studies of Piezo1.
Ruthenium red
Ammoniated ruthenium oxychloride, an inorganic dye, is an inhibitor of other Ca-ATPases (52), although its effect on the RBC enzyme is not well characterized (53) 
Ouabain
Ouabain is a well-known inhibitor of glycolysis when RBCs are in 154 mM NaClsaline (28). Hence the finding of enhanced glycolysis (table S1 Row 23 relative to Row 20) was surprising. The medium contained 30 mM CsCl and since Cs + is a K + congener, we conclude that despite a reduction in Na,K-ATPase activity, other ATPases, including Ca-ATPase, were stimulated by the presence of ouabain. In addition, the yoda1-induced glycolytic-rate enhancement in sucrose-cesium solution was substantial (1.5-fold; Row 23 versus Row 20) and yet it was less than the enhancement in the control sample (2.2-fold; Row 22 versus Row 17).
Again, the responses of the RBCs in these experiments were complex to interpret, and it is difficult with the limited data here to assign a precise mechanism to the effects.
On the other hand, the fact that yoda1 still enhanced the rate of glycolysis in the presence of ouabain implies a lack of a strong direct interaction of it with Piezo1.
Ca 2+ chelation
We explored the hypothesis that the yoda1-induced enhancement of glycolysis was Ca 2+ -mediated. However, a 2-fold rate increase in a sample that had no added Ca 2+ and 2 mM of the divalent-cation chelator trans-1,2-cyclohexanediaminetetraacetic acid (CDTA) was unexpected (Row 31 versus Row 25). On the other hand, depletion of Ca 2+ in the extracellular medium reduced the rate of glycolysis (Row 40 versus Row 37).
Eliminating Ca 2+ from sucrose-saline and reinforcing this with the divalent-cation chelator CDTA, reduced the rate of glycolysis in control RBCs to ~80% of the control value obtained in the absence of yoda1 (Table 1 Row 30 relative to control Row 24).
This effect was separately recorded from RBCs in 152 mM NaCl and 10 mM KCl.
However, a 1.9-fold enhancement of glycolysis, in the presence of 19 M yoda1 under these Ca 2+ -depleted conditions (Table 1 Row 31 relative Row 25) was surprising, but consistent with the notorious difficulty to fully deplete Ca 2+ in RBC suspensions (43).
Overall, we conclude that Ca 2+ is required for the distortion-induced enhancement of glycolysis, and when Piezo1 is held open by yoda1, the value of the extracellular Ca 2+ concentration positively affects the glycolytic rate (Row 41 "No Ca 2+ " but in reality low Ca 2+ concentration, versus Row 38).
Calmidazolium
While calmidazolium inhibits some Ca-ATPases (54) by intercepting calmodulin prior to binding to the enzyme, it is known not to inhibit RBC Ca-ATPase. This is now understood to be the case because calmodulin is persistently bound to Ca-ATPase in these cells (55). Nevertheless, some form of direct effect on Peizo1 seemed worth exploring. Table S1 Row 15 versus the control Row 9 showed that 300 M calmidazolium increased the glycolytic rate by ~60%, but it decreased the response to yoda1 (Row 16 versus control Row 10). Thus, in the presence of yoda1, the previously attained ~3-fold enhancement was reduced to 2.4-fold versus the control (Row 16/Row 9). In other experiments, it was seen that calmidazolium-treated RBCs immediately began hemolysing, and by 5 h at 37 o C over half of the cells in an Ht = 0.65 suspension had ruptured. Therefore, we concluded that the compound was interacting with the cell membrane, increasing its permeability to Ca 2+ by a mechanism other than via Piezo1, and in due course the cells ruptured. If they had transiently resealed, it would have been possible for metabolism to have continued at an increased rate due to the elevated Ca 2+ concentration, but once full rupture had occurred, metabolism would have ceased.
While the rate enhancement by yoda1 in Experiment 6 (Rows 37 and 38) was much smaller than for Experiments 1, 2, and 3, the important result was that calmidazolium stimulated glycolysis in both the absence and presence of yoda1 (Rows 43 and 44), under the conditions of this experiment.
table S1. Rates of [3-13 C]L-lactate production by human RBCs in the absence and presence of the
Piezo1 activator yoda1 and several effector reagents. The rates were estimated by regression of a line onto 13 C-NMR spectral time courses, after an initial lag period of 1 h, recorded over 4 or 5 h from RBC suspensions of Ht = 65%. Each spectrum was recorded in 10 min from 184 transients with an intertransient delay of 20.1 s, using a 30˚ RF pulse duration of 17 s in a pulse-and-acquire sequence.
Sample volume was 3 mL and the various effectors were added in L volumes at the start of the time course. Temperature was set to 37 o C. Suspension media were of two types (mM): NaCl, 114; CsCl, 30; KCl, 10; and CaCl2, 2. And, indicated by a (mM); sucrose, 207; CsCl, 30; NaCl, 10; KCl, 10; and
CaCl2, 2 (except as indicated). S3A ). This beneficial property of 133 Cs + makes experiments on membrane transport of this potassium congener simple, obviating the need to physically separate the cells from their suspension medium in order to measure the 133 Cs + concentrations in the two compartments. Figure S3A (only every second spectrum is shown for clarity) obtained at 37 o C from a suspension of RBCs in saline medium that contained 30 mM CsCl, and to which yoda1 was added (final concentration 19 M), shows a ~2.45 ppm separation of the resonances from the intra-and extracellular populations of the ion. This meant that suspending RBCs in Cs-saline at 37 o C enabled time courses of influx of the cation to be recorded without the need for a shift reagent to bring about separation of the two resonances (as is necessary with most of the other alkali metal ions, e.g. 23 Na + (28)).
Yoda1
In the experiment of fig. S3A , the 133 Cs + influx was initiated by the addition of 19 M yoda1 and the exchange reaction was so fast that ~10% of the full extent of the reaction had been achieved in the first 1 min while the full transmembrane equilibration of the ion was completed in ~30 min. Prior to the addition of yoda1, the 133 Cs NMR spectrum had no detectable signal at the chemical shift of the intracellular population. Typically, this situation lasted for ~1 h. The spectra were of high signal-
to-noise ratio (>20:1) and automatic signal processing yielded time courses typified by those shown in fig. S3B . Yoda1 was added immediately prior to spectral acquisition as 2.0 L of 28.15 mM in dimethyl sulfoxide (DMSO). The total sample volume was 3.0 mL of RBCs (Ht = 0.66), making the initial extracellular yoda1 concentration 55 M, or 19 M averaged over the whole sample.
The RBC suspension medium was (mM): sucrose, 207; CsCl, 30; KCl, 10; NaCl, 10; glucose, 15;
CaCl2, 2; with osmolality 301 mosmol kg -1 . Thus, the initial extracellular [Cs + ] was 30 mM.
Single-transient NMR spectra were acquired every 1 min using a 90˚-pulse duration of 20 s and 8192 data points per FID. Prior to Fourier transformation, a decaying exponential window function with a line broadening factor of 5 Hz was applied. Fitted lines were exponential curves that gave rate constants of 0.10 ± 0.02 and 0.08 ± 0.01 min -1 , respectively. Fitting the first three points to estimate the initial slopes, and using [Cs + ] = 30 mM, implied initial influx rates of 1.74 ± 0.09 and 1.28 ± 0.14 mmol (L RBC) -1 min -1 , respectively (where ± denotes SE, and the rate values are significantly different at P < 0.05).
Immediately after addition of yoda1, an emerging resonance indicated transport of 133 Cs + into the RBCs. The rate of change was much greater than in the 13 C-NMR glycolysis experiments, and the reaction was within 80% of equilibrium after ~20 min.
The resonance from the intracellular species was significantly broader (width-at-half height, 1/2 = 13 Hz) than for the extracellular species (1/2 = 5 Hz). This was consistent with a higher viscosity and binding/exchange inside the cells. Measurement of the integrals of the peaks was straightforward, yielding a progress curve as in fig.   S3B . After calibration of the spectra (see Materials and Methods) and fitting a rising exponential function to the data (upper curve), the initial flux was estimated to be 1.74 ± 0.09 mmol (L RBC) -1 min -1 . The dotted extrapolation line in fig. S3B (upper line) emphasizes the rapidity of the initial influx with ~10% extent of the transport reaction being achieved in the first 1 min of influx.
GsMTx4
GsMTx4 is a peptide from tarantula venom. It is the most specific of the known S3A, the peak integrals of which are in the upper curve. Regression of a rising exponential function onto the lower data set, after concentration calibration, gave an estimate of the initial flux of 1.28 ± 0.14 mmol (L RBC) -1 min -1 , thus its initial rate was 74% of the control. The difference was significant at P < 0.05 in a two-tailed t test.
Supplementary Methods

Gel stretching/compressing apparatus
The apparatus used to variably stretch or compress gels that contain guest molecules or RBCs was first described in 2006 (45); and a description of an adaptation appeared in 2008 (56). In our hands, the principal refinement of the methodology has been in degassing the liquid gelatin prior to adding RBCs.
For the small sample volumes used in analytical NMR spectroscopy the method is described in detail in (30), whereas for the large volumes used inside 10-mm glass tubes, the method is described briefly in the Materials and Methods section and in more detail in the following.
The gelatin solution at ~50 o C is degassed by spinning the ~10 mL volume in a plastic centrifuge tube for 20 s at 2000g; this is sufficient to remove air bubbles. Mixing with the RBC suspension is done over 1 min with a stainless-steel spatula avoiding the introduction of air bubbles. This is followed by drawing the liquid suspension into a silicone tube using a 5-mL disposable syringe attached to its upper end via a short adapting length of plastic tube. A Delrin plug is inserted in the lower end of the silicone tube after slightly compressing it, to create a bleb of sample that recedes into the tube as the plug is pushed in, thus avoiding the introduction of an air bubble. Once the Delrin plug has been inserted, the whole assembly is manually (briskly) swung downwards three times, to centrifuge any untoward bubbles up to the meniscus of the sample. The silicone tube is then inserted into a bottomless thick-walled glass NMR tube where it is allowed to cool, thus enabling the gelatin to set as a gel.
